Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
95% CI 0.1286.09
Dual Incretin Research Peptide GLP-1/GIP Receptor Agonist Overview This dual incretin research peptide is a synthetic GLP-1R/GIPR co-agonist studied in preclinical metabolic research models for its coordinated activation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathways
Our team of professionals is here to help you with any questions you may have and give you the information you need
Diabetes was induced using nicotinamide (NA) and streptozotocin (STZ) in rats, an effective mimic of a T2D-like phenotype ( Method S2 )
Improves Organ Function: Preclinical studies suggest improved organ function due to age-related decline
The presence of the epithelium indicates that mucosally-secreted factors are implicated in the modification of neuronal function
:max_bytes(150000):strip_icc()/GettyImages-1393991964-5452e32871e7431493115521bb14ae22.jpg)
US$ 25.97
US$ 20.56
US$ 29.28
